Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Pharmacogenetics and Genomics|September 7, 2017
Comprehensive assessment of cytochromes P450 and transporter genetics with endoxifen concentration during tamoxifen treatmentLauren A Marcath, Allison M Deal, Emily Van Wieren, et al.
JCO Precision Oncology|February 9, 2022
Clinical Utility of Genomic Profiling in the Treatment of Advanced Sarcomas: A Single-Center ExperienceSpandana Boddu, Christine M Walko, Stephanie Bienasz, et al.
JCO Precision Oncology|July 12, 2021
Identification of Targetable Gene Fusions and Structural Rearrangements to Foster Precision Medicine in KRAS Wild-Type Pancreatic CancerMichael J Fusco, Daryoush Saeed-Vafa, Estrella M Carballido, et al.
British Journal of Clinical Pharmacology|April 25, 2015
In vivo assessment of the metabolic activity of CYP2D6 diplotypes and allelesDaniel L Hertz, Anna C Snavely, Howard L McLeod, et al.
The Oncologist|May 27, 2016
Tamoxifen Dose Escalation in Patients With Diminished CYP2D6 Activity Normalizes Endoxifen Concentrations Without Increasing ToxicityDaniel L Hertz, Allison Deal, Joseph G Ibrahim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Genotype-guided tamoxifen dosing increases active metabolite exposure in women with reduced CYP2D6 metabolism: a multicenter studyWilliam J Irvin, Christine M Walko, Karen E Weck, et al.
Neuro-Oncology|November 11, 2020
Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I studySolmaz Sahebjam, Peter A Forsyth, Nam D Tran, et al.
Ebiomedicine|June 27, 2025
A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancerMaxwell R Lloyd, Rosario Chica-Parrado, Caroline M Weipert, et al.
Pharmacogenomics|December 19, 2009
Institutional profile. UNC Institute for Pharmacogenomics and Individualized Therapy: interdisciplinary research for individual careTejinder K Rakhra-Burris, J Todd Auman, Patricia Deverka, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 6, 2018
Identification of Clonal Hematopoiesis Mutations in Solid Tumor Patients Undergoing Unpaired Next-Generation Sequencing AssaysCatherine C Coombs, Nancy K Gillis, Xianming Tan, et al.
Pageof 5